Author

Tatsuro Takano

Observed name: Tatsuro TAKANO

Institution: Fujisawa City Hospital

Observed institutions: Fujisawa City Hospital, Yokohama City University Medical Center, Yokohama Rosai Hospital, Yokohama City University

ORCID: 0000-0002-5422-3790

Observed ORCID: 0000-0002-5422-3790

OpenAlex ID: A5008359331

Influence of Pitavastatin on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus

2008 · Tadashi Yamakawa, Tatsuro Takano, et al. · Journal of Atherosclerosis and Thrombosis · 102

Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA)

2018 · Rika Sakamoto, Tadashi Yamakawa, et al. · PLoS ONE · 72

Effect of Colestimide Therapy for Glycemic Control in Type 2 Diabetes Mellitus with Hypercholesterolemia

2007 · Tadashi YAMAKAWA, Tatsuro TAKANO, et al. · Endocrine Journal · 70

Influences of Statins on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus

2006 · Tatsuro Takano, Tadashi Yamakawa, et al. · Journal of Atherosclerosis and Thrombosis · 52

Normal Delivery Following an Uneventful Pregnancy in a Japanese Acromegalic Patient after Discontinuation of Octreotide Long Acting Release Formulation at an Early Phase of Pregnancy

2006 · Tatsuro TAKANO, Jun SAITO, et al. · Endocrine Journal · 29

Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial

2024 · Kayo Waki, Mitsuhiko Nara, et al. · npj Digital Medicine · 27

Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia

2015 · Yumiko Komatsu, Akinobu Nakamura, et al. · Endocrine Journal · 23

Efficacy of the Self-management Support System DialBetesPlus for Diabetic Kidney Disease: Protocol for a Randomized Controlled Trial

2021 · Yuki Kawai, Akiko Sankoda, et al. · JMIR Research Protocols · 16

Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study

2019 · Jun Suzuki, Tadashi Yamakawa, et al. · Endocrine Journal · 13

Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease

2014 · Yoshinobu Kondo, Junko Hamai, et al. · Endocrine Journal · 6

Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes

2022 · Shunsuke Yamazaki, Tatsuro Takano, et al. · Diabetes Therapy · 4

Author Correction: Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial

2024 · Kayo Waki, Mitsuhiko Nara, et al. · npj Digital Medicine · 1

Endocrine. Interesting cases. The 35th collection. Gonad and others. A case of non-insulin-dependent diabetes mellitus that repeatedl ycontracted the myocardial infarction before the menopause, and exhibited positive anti-insulin antibody and insulin resistance.

1999 · Yuko Terada, Atsushi Okamura, et al. · ホルモンと臨床

Works count: 13

Citation count: 415

H-index: 9

I10-index: 9